Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))

Joep C. Defesche; Claudia Stefanutti; Gisle Langslet; Paul N. Hopkins; Werner Seiz; Marie T. Baccara-Dinet; Sara C. Hamon; Poulabi Banerjee; John J. P. Kastelein

doi:10.1016/j.jacl.2020.09.010

Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))

Joep C. Defesche
, Claudia Stefanutti
, Gisle Langslet
, Paul N. Hopkins
, Werner Seiz
, Marie T. Baccara-Dinet
, Sara C. Hamon
, Poulabi Banerjee
, John J. P. Kastelein^*

^*Corresponding author for this work

Amsterdam UMC - University of Amsterdam
University of Rome La Sapienza
University of Oslo
University of Utah
Translational Medicine and Early Development, Sanofi, Frankfurt, Germany
Sanofi-Aventis
Regeneron Pharmaceuticals, Inc.

Research output: Contribution to journal › Erratum/Corrigendum › Academic

Abstract

The authors regret that the row labels for the following data in Table 1 were transposed: ApoB and non-HDL-C; and TG and Lp(a). The authors would like to apologise for any inconvenience caused.

Original language	English
Pages (from-to)	742
Number of pages	1
Journal	Journal of clinical lipidology
Volume	14
Issue number	5
DOIs	https://doi.org/10.1016/j.jacl.2020.09.010
Publication status	Published - 1 Sept 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jacl.2020.09.010

Fingerprint

Dive into the research topics of 'Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))'. Together they form a unique fingerprint.

Cite this

Defesche, J. C., Stefanutti, C., Langslet, G., Hopkins, P. N., Seiz, W., Baccara-Dinet, M. T., Hamon, S. C., Banerjee, P., & Kastelein, J. J. P. (2020). Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016)). Journal of clinical lipidology, 14(5), 742. https://doi.org/10.1016/j.jacl.2020.09.010

Defesche, Joep C. ; Stefanutti, Claudia ; Langslet, Gisle et al. / Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016)). In: Journal of clinical lipidology. 2020 ; Vol. 14, No. 5. pp. 742.

@article{dfc989602a344c10a21a8cb3c99d658f,

title = "Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))",

abstract = "The authors regret that the row labels for the following data in Table 1 were transposed: ApoB and non-HDL-C; and TG and Lp(a). The authors would like to apologise for any inconvenience caused.",

author = "Defesche, \{Joep C.\} and Claudia Stefanutti and Gisle Langslet and Hopkins, \{Paul N.\} and Werner Seiz and Baccara-Dinet, \{Marie T.\} and Hamon, \{Sara C.\} and Poulabi Banerjee and Kastelein, \{John J. P.\}",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.jacl.2020.09.010",

language = "English",

volume = "14",

pages = "742",

journal = "Journal of clinical lipidology",

issn = "1933-2874",

publisher = "Elsevier BV",

number = "5",

}

Defesche, JC, Stefanutti, C, Langslet, G, Hopkins, PN, Seiz, W, Baccara-Dinet, MT, Hamon, SC, Banerjee, P & Kastelein, JJP 2020, 'Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))', Journal of clinical lipidology, vol. 14, no. 5, pp. 742. https://doi.org/10.1016/j.jacl.2020.09.010

Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016)). / Defesche, Joep C.; Stefanutti, Claudia; Langslet, Gisle et al.
In: Journal of clinical lipidology, Vol. 14, No. 5, 01.09.2020, p. 742.

Research output: Contribution to journal › Erratum/Corrigendum › Academic

TY - JOUR

T1 - Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))

AU - Defesche, Joep C.

AU - Stefanutti, Claudia

AU - Langslet, Gisle

AU - Hopkins, Paul N.

AU - Seiz, Werner

AU - Baccara-Dinet, Marie T.

AU - Hamon, Sara C.

AU - Banerjee, Poulabi

AU - Kastelein, John J. P.

PY - 2020/9/1

Y1 - 2020/9/1

N2 - The authors regret that the row labels for the following data in Table 1 were transposed: ApoB and non-HDL-C; and TG and Lp(a). The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the row labels for the following data in Table 1 were transposed: ApoB and non-HDL-C; and TG and Lp(a). The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85094315608

U2 - 10.1016/j.jacl.2020.09.010

DO - 10.1016/j.jacl.2020.09.010

M3 - Erratum/Corrigendum

C2 - 33138962

SN - 1933-2874

VL - 14

SP - 742

JO - Journal of clinical lipidology

JF - Journal of clinical lipidology

IS - 5

ER -

Defesche JC, Stefanutti C, Langslet G, Hopkins PN, Seiz W, Baccara-Dinet MT et al. Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016)). Journal of clinical lipidology. 2020 Sept 1;14(5):742. doi: 10.1016/j.jacl.2020.09.010

Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this